330 related articles for article (PubMed ID: 6294698)
21. Lesion of vagal afferent terminals impairs glucagon-induced suppression of food intake.
Weatherford SC; Ritter S
Physiol Behav; 1988; 43(5):645-50. PubMed ID: 3200921
[TBL] [Abstract][Full Text] [Related]
22. [Peptides of digestive system and brain. Model of the cholecystokinin].
Gibbs J; Smith GP
Ann Endocrinol (Paris); 1988; 49(2):113-20. PubMed ID: 3048188
[TBL] [Abstract][Full Text] [Related]
23. The anorexigenic effect of cholecystokinin octapeptide in a goldfish model is mediated by the vagal afferent and subsequently through the melanocortin- and corticotropin-releasing hormone-signaling pathways.
Kang KS; Yahashi S; Azuma M; Matsuda K
Peptides; 2010 Nov; 31(11):2130-4. PubMed ID: 20688118
[TBL] [Abstract][Full Text] [Related]
24. Role of gastric distention in cholecystokinin's satiety effect in golden hamsters.
Miceli MO
Physiol Behav; 1985 Dec; 35(6):945-53. PubMed ID: 4095187
[TBL] [Abstract][Full Text] [Related]
25. Subdiaphragmatic vagal deafferentation fails to block feeding-suppressive effects of LPS and IL-1 beta in rats.
Schwartz GJ; Plata-Salamán CR; Langhans W
Am J Physiol; 1997 Sep; 273(3 Pt 2):R1193-8. PubMed ID: 9321903
[TBL] [Abstract][Full Text] [Related]
26. The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats.
Koda S; Date Y; Murakami N; Shimbara T; Hanada T; Toshinai K; Niijima A; Furuya M; Inomata N; Osuye K; Nakazato M
Endocrinology; 2005 May; 146(5):2369-75. PubMed ID: 15718279
[TBL] [Abstract][Full Text] [Related]
27. Cholecystokinin-induced excitation in the substantia nigra: evidence for peripheral and central components.
Hommer DW; Palkovits M; Crawley JN; Paul SM; Skirboll LR
J Neurosci; 1985 Jun; 5(6):1387-92. PubMed ID: 4009236
[TBL] [Abstract][Full Text] [Related]
28. Satiety effects of cholecystokinin and caerulein in rabbits.
Houpt TR; Anika SM; Wolff NC
Am J Physiol; 1978 Jul; 235(1):R23-8. PubMed ID: 677336
[TBL] [Abstract][Full Text] [Related]
29. Cholecystokinin and bombesin act independently to decrease food intake in the rat.
Stein LJ; Woods SC
Peptides; 1981; 2(4):431-6. PubMed ID: 6276871
[TBL] [Abstract][Full Text] [Related]
30. Lack of interaction between peripheral injection of CCK and obestatin in the regulation of gastric satiety signaling in rodents.
Gourcerol G; Million M; Adelson DW; Wang Y; Wang L; Rivier J; St-Pierre DH; Taché Y
Peptides; 2006 Nov; 27(11):2811-9. PubMed ID: 16934368
[TBL] [Abstract][Full Text] [Related]
31. Modulation of the satiety effect of cholecystokinin by estradiol.
Butera PC; Bradway DM; Cataldo NJ
Physiol Behav; 1993 Jun; 53(6):1235-8. PubMed ID: 8346313
[TBL] [Abstract][Full Text] [Related]
32. Vagal and splanchnic afferents are not necessary for the anorexia produced by peripheral IL-1beta, LPS, and MDP.
Porter MH; Hrupka BJ; Langhans W; Schwartz GJ
Am J Physiol; 1998 Aug; 275(2):R384-9. PubMed ID: 9688672
[TBL] [Abstract][Full Text] [Related]
33. Abdominal vagotomy does not block the satiety effect of bombesin in the rat.
Smith GP; Jerome C; Gibbs J
Peptides; 1981; 2(4):409-11. PubMed ID: 6276868
[TBL] [Abstract][Full Text] [Related]
34. Urocortins and cholecystokinin-8 act synergistically to increase satiation in lean but not obese mice: involvement of corticotropin-releasing factor receptor-2 pathway.
Gourcerol G; Wang L; Wang YH; Million M; Taché Y
Endocrinology; 2007 Dec; 148(12):6115-23. PubMed ID: 17932219
[TBL] [Abstract][Full Text] [Related]
35. Cholecystokinin octapeptide analogues suppress food intake via central CCK-A receptors in mice.
Hirosue Y; Inui A; Teranishi A; Miura M; Nakajima M; Okita M; Nakajima Y; Himori N; Baba S; Kasuga M
Am J Physiol; 1993 Sep; 265(3 Pt 2):R481-6. PubMed ID: 8214137
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic secretion stimulated by CCK is not mediated by capsaicin-sensitive vagal afferent pathway in awake rats.
Guan D; Phillips WT; Green GM
Am J Physiol; 1996 May; 270(5 Pt 1):G881-6. PubMed ID: 8967501
[TBL] [Abstract][Full Text] [Related]
37. Hindbrain leptin receptor stimulation enhances the anorexic response to cholecystokinin.
Williams DL; Baskin DG; Schwartz MW
Am J Physiol Regul Integr Comp Physiol; 2009 Nov; 297(5):R1238-46. PubMed ID: 19726710
[TBL] [Abstract][Full Text] [Related]
38. Role of cholecystokinin and opioid peptides in control of food intake.
Baile CA; McLaughlin CL; Della-Fera MA
Physiol Rev; 1986 Jan; 66(1):172-234. PubMed ID: 2868468
[TBL] [Abstract][Full Text] [Related]
39. 2-Naphthalenesulphanyl-L-aspartyl-2-(phenethyl) amide (2-NAP) and food intake in rats: evidence that endogenous peripheral CCK does not play a major role as a satiety factor.
Ebenezer IS; Baldwin BA
Br J Pharmacol; 1995 Nov; 116(5):2371-4. PubMed ID: 8581271
[TBL] [Abstract][Full Text] [Related]
40. Neuroleptic-induced chewing movements in the rat are suppressed by peripherally but not centrally administered CCK and abolished by bilateral subdiaphragmatic vagotomy.
Stoessl AJ; Polanski E
Neuropharmacology; 1993 Jun; 32(6):555-60. PubMed ID: 8101638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
